Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Arnott

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Crohn'S & Colitis|December 9, 2023
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative ColitisBeatriz Gros, Mairi Goodall, Nik Plevris, et al.
Journal of Crohn'S & Colitis|December 11, 2024
Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted ComparisonBeatriz Gros, Nathan Constantine-Cooke, Jake Kennedy, et al.
FEBS Letters|December 2, 1999
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomasY Chuman, A Bergman, T Ueno, et al.
Human Molecular Genetics|July 7, 2007
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategyJohan Van Limbergen, Elaine R Nimmo, Richard K Russell, et al.
United European Gastroenterology Journal|February 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohortBeatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, et al.
Inflammatory Bowel Diseases|September 18, 2010
Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysisColin L Noble, Alexander R Abbas, Charles W Lees, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 22, 2020
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, ScotlandPhilip W Jenkinson, Nikolas Plevris, Mathew Lyons, et al.
The Journal of Experimental Medicine|June 1, 1996
Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjectsF di Marzo Veronese, D Arnott, V Barnaba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's DiseaseNikolas Plevris, James Fulforth, Mathew Lyons, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 1, 2014
Diverticular disease in Scotland: 2000-2010H M Paterson, I D Arnott, R J Nicholls, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Crohn'S & Colitis|December 9, 2023
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative ColitisBeatriz Gros, Mairi Goodall, Nik Plevris, et al.
Journal of Crohn'S & Colitis|December 11, 2024
Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted ComparisonBeatriz Gros, Nathan Constantine-Cooke, Jake Kennedy, et al.
FEBS Letters|December 2, 1999
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomasY Chuman, A Bergman, T Ueno, et al.
Human Molecular Genetics|July 7, 2007
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategyJohan Van Limbergen, Elaine R Nimmo, Richard K Russell, et al.
United European Gastroenterology Journal|February 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohortBeatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, et al.
Inflammatory Bowel Diseases|September 18, 2010
Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysisColin L Noble, Alexander R Abbas, Charles W Lees, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 22, 2020
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, ScotlandPhilip W Jenkinson, Nikolas Plevris, Mathew Lyons, et al.
The Journal of Experimental Medicine|June 1, 1996
Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjectsF di Marzo Veronese, D Arnott, V Barnaba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's DiseaseNikolas Plevris, James Fulforth, Mathew Lyons, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 1, 2014
Diverticular disease in Scotland: 2000-2010H M Paterson, I D Arnott, R J Nicholls, et al.
Pageof 8